What is CCSVI Chronic Cerebro-Spinal Venous Insufficiency Therapy?
Chronic cerebro-spinal venous insufficiency (CCSVI) is a syndrome in which the flow of blood in the cervical (neck) and thoracic (chest) veins is compromised and less efficient. It is proposed that insufficient venous blood flow promotes development of brain dysfunction.
Reported Purpose & Perceived Effectiveness
| Perceived Effectiveness | |||||||
|---|---|---|---|---|---|---|---|
| Purpose | # of patients | # of patients with evaluations | Major | Moderate | Slight | None | Can’t tell |
| MS (Multiple Sclerosis) | 62 | 33 |
|
|
|
|
|
| CCSVI (Chronic Cerebrospinal Venous Insufficiency) | 36 | 17 |
|
|
|
|
|
| Support circulatory health | 2 | 2 |
|
|
|||
| General health | 2 | 1 |
|
||||
| Internal Jugular Vein Stenosis | 2 | 2 |
|
||||
| Stiffness/Spasticity | 1 | 1 |
|
||||
See all 7 patients currently having CCSVI Chronic Cerebro-Spinal Venous Insufficiency Therapy
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with CCSVI Chronic Cerebro-Spinal Venous Insufficiency Therapy
| Hospitalization | 7 | |
|---|---|---|
| Neck pain | 2 | |
| Hospitalization | 2 | |
| Cold legs | 1 | |
| Pain in lower back | 1 | |
| Muscle spasms | 1 | |
| See all 18 reported side effects ▼ | ||
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of CCSVI Chronic Cerebro-Spinal Venous Insufficiency Therapy
Always |
29 | 47% |
|
|---|---|---|---|
Usually |
4 | 6% |
|
Sometimes |
4 | 6% |
|
Never |
25 | 40% |
|
Burden
Difficulty being on treatment
Burden of CCSVI Chronic Cerebro-Spinal Venous Insufficiency Therapy
Very |
1 | 2% |
|
|---|---|---|---|
Somewhat |
7 | 11% |
|
A little |
13 | 21% |
|
Not at all |
41 | 66% |
|
Cost
Paid out of pocket
Cost of CCSVI Chronic Cerebro-Spinal Venous Insufficiency Therapy
$200+ |
21 | 64% |
|
|---|---|---|---|
$100-199 |
1 | 3% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
11 | 33% |
|
Updating results…












First
Prev
